A review of extended coronavirus disease 2019 (COVID-19) isolation duration among inpatients in a tertiary-care hospital

A review of extended coronavirus disease 2019 (COVID-19) isolation duration among inpatients in a tertiary-care hospital—Iowa, 2020–2022

Published:2023-08-02 Issue:1 Volume:45 Page:110-113
ISSN:0899-823X
Container-title:Infection Control & Hospital Epidemiology
language:en
Short-container-title:Infect. Control Hosp. Epidemiol.

Author:

Abosi Oluchi J.^ORCID,Trannel Alexandra^ORCID,Schwartzhoff Patrick^ORCID,Ackman Mark,Zilles Barbara,Marra Alexandre R.^ORCID,Dains Angelique,Naito Toshio^ORCID,Salinas Jorge L.^ORCID,Diekema Daniel J.,Hanna Beth,Murphy Jaime P.^ORCID,Wellington Melanie^ORCID,Brust Karen,Kobayashi Takaaki^ORCID

Abstract

AbstractOf the 2,668 patients admitted with coronavirus disease 2019 (COVID-19), 4% underwent prolonged isolation for >20 days. Reasons for extended isolation were inconsistent with Centers for Disease Control and Prevention (CDC) guidelines in 25% of these patients and were questionable in 54% due to an ongoing critically ill condition at day 20 without CDC-defined immunocompromised status.

Publisher

Cambridge University Press (CUP)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference9 articles.

1. Adverse effects of contact isolation

2. Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020

3. 4. Who is moderately or severely immunocompromised? Centers for Disease Control and Prevention website. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html#mod. Accessed October 26, 2022.

4. 1. Ending isolation and precautions for people with COVID-19: interim guidance. Centers for Disease Control and Prevention website. https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html. Published 2022. Accessed November 20, 2022.

5. Adverse effects of isolation in hospitalised patients: a systematic review